You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Ytrium-90 (Y-90)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hepatocellular Carcinoma (HCC), Unresectable Hepatocellular Carcinoma Trial in Ann Arbor (drug, device, radiation, diagnostic

Recruiting
  • Hepatocellular Carcinoma (HCC)
  • Unresectable Hepatocellular Carcinoma
  • Ann Arbor, Michigan
    University of Michigan Rogel Cancer Center
Dec 16, 2021

Cancer Trial in Manchester (Y90-PET-CT scan)

Recruiting
  • Cancer
  • Y90-PET-CT scan
  • Manchester, United Kingdom
    The Christie NHS - Nuclear Medicine Department
Nov 7, 2023

CNS Lymphoma Trial in Essen ([90Y]Y-PentixaTher)

Recruiting
  • CNS Lymphoma
  • Essen, Germany
    University Hospital Essen
Nov 16, 2023

Pancreatic Neuroendocrine Tumor Trial in Milano (peptide receptor radionuclide therapy with Y-90-DOTATOC)

Recruiting
  • Pancreatic Neuroendocrine Tumor
  • peptide receptor radionuclide therapy with Y-90-DOTATOC
  • Milano, Italy
  • +1 more
Sep 30, 2022

BCLC Stage B Hepatocellular Carcinoma, BCLC Stage C Hepatocellular Carcinoma, Locally Advanced Hepatocellular Carcinoma Trial in

Withdrawn
  • BCLC Stage B Hepatocellular Carcinoma
  • +4 more
  • Atezolizumab
  • +3 more
  • (no location specified)
Dec 12, 2022

Carcinoma, Hepatocellular Trial (Therasphere 90Y, Microwave Ablation)

Not yet recruiting
  • Carcinoma, Hepatocellular
  • Therasphere 90Y
  • Microwave Ablation
  • (no location specified)
Jul 12, 2023

Bile Duct Cancer, Cholangiocarcinoma, Cholangiocarcinoma Non-resectable Trial in Boston (Gemcitabine, Cisplatin, Durvalumab)

Not yet recruiting
  • Bile Duct Cancer
  • +4 more
  • Boston, Massachusetts
    Beth Israel Deaconess Medical Center
Jan 23, 2023

Hepatocellular Carcinoma Trial in Guangzhou (SIRT)

Not yet recruiting
  • Hepatocellular Carcinoma
  • SIRT
  • Guangzhou, Guangdong, China
    The Second Affiliated Hospital of Guangzhou Medical University
Aug 9, 2023

Locally Advanced Hepatocellular Carcinoma Trial in Singapore (SIRT-Y90 with Atezolizumab + Bevacizumab, SIRT-Y90 with Placebo

Recruiting
  • Locally Advanced Hepatocellular Carcinoma
  • SIRT-Y90 with Atezolizumab + Bevacizumab
  • SIRT-Y90 with Placebo (IV)
  • Singapore, Singapore
  • +1 more
Jan 26, 2023

Liver Cancer, Hepatoma Trial (Yttrium 90 (TheraSphere))

Completed
  • Liver Cancer
  • Hepatoma
  • Yttrium 90 (TheraSphere)
  • (no location specified)
Sep 28, 2022

Hepatocellular Carcinoma Trial in Guangzhou (Lenvatinib, sintilimab plus SIRT)

Not yet recruiting
  • Hepatocellular Carcinoma
  • Lenvatinib, sintilimab plus SIRT
  • Guangzhou, Guangdong, China
    The Second Affiliated Hospital of Guangzhou Medical University
Aug 8, 2023

Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Metastatic Carcinoma in the Liver Trial in Atlanta

Not yet recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +3 more
  • Y-90 SIR-Spheres
  • +2 more
  • Atlanta, Georgia
    Emory University Hospital/Winship Cancer Institute
Jun 7, 2022

Stage III Hepatocellular Carcinoma AJCC v8, Stage IIIA Hepatocellular Carcinoma AJCC v8, Stage IIIB Hepatocellular Carcinoma

Completed
  • Stage III Hepatocellular Carcinoma AJCC v8
  • +6 more
  • Yttrium Y 90 Glass Microspheres
  • Houston, Texas
    M D Anderson Cancer Center
Oct 12, 2022

Hepatocellular Carcinoma Trial in United States (Y-90 TARE, Atezolizumab, Bevacizumab)

Recruiting
  • Hepatocellular Carcinoma
  • Y-90 TARE
  • +2 more
  • Washington, District of Columbia
  • +5 more
Jan 18, 2023

Colon Cancer, Rectal Cancer, Liver Metastases Trial in San Francisco (Tas-102, SIR-Sphere)

Completed
  • Colon Cancer
  • +2 more
  • San Francisco, California
    University of California San Francisco
Jul 28, 2022

Metastatic Liver Carcinoma, Stage IV Liver Cancer, Stage IVA Liver Cancer Trial in Houston (procedure, radiation, other)

Active, not recruiting
  • Metastatic Liver Carcinoma
  • +3 more
  • Angiography
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 22, 2022

Hepatocellular Carcinoma, Stage I Hepatocellular Carcinoma AJCC v8, Stage IA Hepatocellular Carcinoma AJCC v8 Trial in Portland

Not yet recruiting
  • Hepatocellular Carcinoma
  • +8 more
  • Quality of Life
  • +3 more
  • Portland, Oregon
  • +1 more
Jun 20, 2022

Renal Cell Carcinoma, Kidney Tumor, Renal Cancer Trial in New York (Yttrium-90 conjugated chimeric G250 (^90Y-DOTA-cG250))

Completed
Has Results
  • Renal Cell Carcinoma
  • +3 more
  • Yttrium-90 conjugated chimeric G250 (^90Y-DOTA-cG250)
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Oct 3, 2022

Unresectable Hepatocellular Carcinoma, BCLC Stage A Hepatocellular Carcinoma, BCLC Stage B Hepatocellular Carcinoma Trial in

Recruiting
  • Unresectable Hepatocellular Carcinoma
  • +3 more
  • Resin microspheres containing yttrium-90 (Y-90)
  • Mission Hills, California
  • +15 more
Sep 15, 2022

Colorectal Tumors Trial in Hangzhou (Resin microspheres containing yttrium-90 (Y-90))

Not yet recruiting
  • Colorectal Neoplasms
  • Resin microspheres containing yttrium-90 (Y-90)
  • Hangzhou, Zhejiang, China
    Sir Run Run Shaw Hospital (SRRSH), affiliated with the Zhejiang
Oct 11, 2023

Neuroendocrine Tumors, Meningioma, Neuroblastoma Trial in Iowa City (radiation, diagnostic test, drug)

Active, not recruiting
  • Neuroendocrine Tumors
  • +3 more
  • 90Y-DOTA tyr3-Octreotide
  • +2 more
  • Iowa City, Iowa
    University of Iowa Hospitals and Clinics
Oct 6, 2022

Colorectal Cancer Metastatic, Colon Cancer, Metastatic Colorectal Cancer Trial in Iowa City (Durvalumab, Yttrium-90

Recruiting
  • Colorectal Cancer Metastatic
  • +9 more
  • Iowa City, Iowa
    University of Iowa Hospitals and Clinics
Mar 24, 2022

Liver Cancer Trial in Houston (device, diagnostic test, procedure)

Not yet recruiting
  • Liver Cancer
  • TriSalus™ TriNav™Infusion System
  • +2 more
  • Houston, Texas
    MD Anderson Cancer Center
Feb 23, 2023

Intrahepatic Cholangiocarcinoma Trial in Charleston (SIR-Spheres microspheres (Yttrium-90 Microspheres), Gemcitabine, Cisplatin)

Active, not recruiting
  • Intrahepatic Cholangiocarcinoma
  • SIR-Spheres microspheres (Yttrium-90 Microspheres)
  • +2 more
  • Charleston, South Carolina
    Medical University of South Carolina
Nov 11, 2021

Hepatocellular Carcinoma Trial in Chicago (Atezolizumab and Bevacizumab, Y90 + TKI)

Not yet recruiting
  • Hepatocellular Carcinoma
  • Atezolizumab and Bevacizumab
  • Y90 + TKI
  • Chicago, Illinois
    Northwestern University
Nov 11, 2022